《3 Undervalued Healthcare Stocks Invstors Can Buy Right Now》
OSCR 目前被低估，公允价值高于 41 美元，现价约 30 美元，意味着在增长与成本控制推动下，12-18 个月内有超过 34% 的上行空间。
最后但同样重要的是Oscar Health，它是在将人工智能整合到运营中以提升效率和业绩方面最顶尖的医疗保健公司之一。它是自2024年以来增长最快的医疗保健公司之一。它实现了超过40%的复合年收入增长率。
管理层预计，从现在到2030年，复合年收入增长率将超过20%。它正在控制成本，而随着收入和净利润的扩张，利润也在改善。
Last but not least, Oscar Health, one of the top healthcare companies in terms of integrating artificial intelligence into its operations to improve efficiency and performance.
It is one of the fastest growing healthcare companies since 2024. It has achieved a compound annual revenue growth rate of over 40%. Management anticipates compound annual revenue growth rates exceeding 20% from now until 2030.
It is controlling costs, and profits are improving as a result of this expansion in revenue and net profit.